Eli Lilly and Company Aktie News

Eli Lilly is a top healthcare company that's not only generating impressive growth right now, but continuing to invest in its future. American Express' strong brand and clientele make it a resilient financial stock to invest in for the long haul.

Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools and automated labs to unlock efficiency gains across their pipeline.

MoneyShow presents top investment ideas for 2026 from their contributors. This year's edition presents a mix of metals plays, financial stocks, deep value names, high-octane growth and tech stocks, and beaten-down REITs that offer solid income and turnaround potential. Part 3 of this series includes Eli Lilly, Enterprise Products Partners, Expand Energy Corp., Federal Agricultural Mortgage Corp...

Retatrutide's recent trial results suggest it may be even better than Eli Lilly's already approved GLP-1 medication, tirzepatide. Besides weight loss, retatrutide helped many people with osteoarthritis in their knees feel completely pain-free by the end of the study.

Eli Lilly's weight-loss drugs are experiencing rapid growth. It still has a long way to go to help curb obesity rates around the globe.

These players each are leaders in their specialty areas and have generated billions of dollars in revenue. This list includes a biotech stock, a pharma player, and a medical device company.

Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has now introduced a pill version of its GLP-1 weight loss drug.

Eli Lilly and Company (LLY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript